Abstract:Background: Lung cancer, especially non-small cell lung cancer (NSCLC), is one of the most-deadly malignancies worldwide. Lung cancer has a worse 5-year survival rate than many primary malignancies. Thus, the early detection and prognosis prediction of lung cancer are crucial. The early detection and prognosis prediction of lung cancer have improved with the widespread use of artificial intelligence (AI) technologies. This meta-analysis examined the accuracy and efficacy of AI-based models in predicting lymph node metastasis (LNM) in NSCLC patients using imaging data. Our findings could help clinicians predict patient prognosis and select alternative therapies. Methods: We searched the PubMed, Web of Science, Cochrane Library, and Embase databases for relevant articles published up to January 31, 2024. Two reviewers individually evaluated all the retrieved articles to assess their eligibility for inclusion in the meta-analysis. The systematic assessment and meta-analysis comprised articles that satisfied the inclusion criteria (e.g., randomized or non-randomized trials, and observational studies) and exclusion criteria (e.g., articles not published in English), and provided data for the quantitative synthesis. The quality of the included articles was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). The pooled sensitivity, specificity, and area under the curve (AUC) were used to evaluate the ability of AI-based imaging models to predict LNM in NSCLC patients. Sources of heterogeneity were investigated using meta-regression. Covariates, including country, sample size, imaging modality, model validation technique, and model algorithm, were examined in the subgroup analysis. Results: The final meta-analysis comprised 11 retrospective studies of 6,088 NSCLC patients, of whom 1,483 had LNM. The pooled sensitivity, specificity, and AUC of the AI-based imaging model for predicting LNM in NSCLC patients were 0.87 [95% confidence interval (CI): 0.80-0.91], 0.85 (95% CI: 0.78-0.89), and 0.92 (95% CI: 0.90-0.94). Based on the QUADAS-2 results, a risk of bias was detected in the patient selection and diagnostic tests of the included articles. However, the quality of the included articles was generally acceptable. The pooled sensitivity and specificity were heterogeneous (I2>75%). The meta-regression and subgroup analyses showed that imaging modality [computed tomography (CT) or positron emission tomography (PET)/CT], and the neural network method model design significantly affected heterogeneity of this study. Models employing sample size data from a single center and the least absolute shrinkage and selection operator (LASSO) method had greater sensitivity than other techniques. Using the Deek' s funnel plot, no publishing bias was found. The results of the sensitivity analysis showed that deleting each article one by one did not change the findings. Conclusions: Imaging data models based on AI algorithms have good diagnostic accuracy in predicting LNM in patients with NSCLC and could be applied in clinical settings.

An artificial intelligence-based model exploiting H&E images to predict recurrence in negative sentinel lymph-node melanoma patients

A 18F-FDG PET/CT-based Deep Learning-Radiomics-clinical Model for Prediction of Cervical Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

Artificial Intelligence to Predict the Risk of Lymph Node Metastasis in T2 Colorectal Cancer

Using artificial intelligence based imaging to predict lymph node metastasis in non-small cell lung cancer: a systematic review and meta-analysis

A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients

Can Machine Learning Models Detect and Predict Lymph Node Involvement in Prostate Cancer? A Comprehensive Systematic Review

Artificial intelligence-assisted metastasis and prognosis model for patients with nodular melanoma

Artificial intelligence (AI) –powered H&E whole-slide image (WSI) analysis to predict recurrence in hormone receptor positive (HR+) early breast cancer (EBC).

Utilizing deep learning model for assessing melanocytic density in resection margins of lentigo maligna

Clinical Melanoma Diagnosis with Artificial Intelligence: Insights from a Prospective Multicenter Study

Machine learning to predict overall short-term mortality in cutaneous melanoma

A ultrasound-based radiomic approach to predict the nodal status in clinically negative breast cancer patients

Evaluation of a Deep Learning Model for Metastatic Squamous Cell Carcinoma Prediction From Whole Slide Images

Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.

Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer with Deep Learning

Machine learning directed sentinel lymph node biopsy in cutaneous head and neck melanoma

Radiomics Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Sentinel Lymph Node Metastasis in Breast Cancer

Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma

Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients

Melanoma imaging and diagnosis: What does the future hold?

Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images